Showing results 6 to 9 of 9
Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice Yang, Hanseul; Lee, Sung-Su; Lee, Seung-Joo; Kim, Kang-San; Yang, Ye-Seul; Kim, Jeong-Hoon; Adams, Ralf H.; et al, JOURNAL OF CLINICAL INVESTIGATION, v.123, no.1, pp.418 - 431, 2013-01 |
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy D''Amico, Gabriela; Korhonen, Emilia A.; Anisimov, Andrey; Zarkada, Georgia; Holopainen, Tanja; Haegerling, Rene; Kiefer, Friedemann; et al, JOURNAL OF CLINICAL INVESTIGATION, v.124, no.2, pp.824 - 834, 2014-02 |
Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption Kim, Chan; Yang, Hanseul; Fukushima, Yoko; Saw, Phei Er; Lee, Junyeop; Park, Jin-Sung; Park, Intae; et al, CANCER CELL, v.25, no.1, pp.102 - 117, 2014-01 |
YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells Sivaraj, Kishor K.; Dharmalingam, Backialakshmi; Mohanakrishnan, Vishal; Jeong, Hyun-Woo; Kato, Katsuhiro; Schroeder, Silke; Adams, Susanne; et al, ELIFE, v.9, 2020-01 |
Discover